CTRI/2024/02/063165Not yet recruitingPhase 3
Efficacy Of Loha Rasayana and Vyoshadi Saktu On Atherogenic Index Of Plasma (AIP) In Patients Of Metabolic Syndrome - An Open Labelled Randomized Comparative Clinical Trial. - METS
Trial Snapshot
- Phase
- Phase 3
- Status
- Not yet recruiting
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Patients fulfilling the Diagnostic criteria of Metabolic Syndrome.
- •Patients fit for Virechana Karma.
Exclusion Criteria
- •Age group below 30 years and above 60 years.
- •Patients not fulfilling the Diagnostic criteria of Metabolic Syndrome
Investigators
Similar Trials
Completed
Phase 3
Ayurvedic management of Migraine with the help of Laghu Sutashekhara Rasa Tablet and Nasal drop of Brihata Dashmoola TailaCTRI/2022/01/039319ITRA Jamnagar44
Not yet recruiting
Phase 3
Managing Migraine through Ayurveda with the intake of Tablet Laghu Sutashekhar Rasa and Brihat Dashmoola Taila as Nasal drops.CTRI/2023/04/051278ITRA Jamnagar
Not yet recruiting
Phase 2
Ayurvedic management of Migraine by using Laghu Sutashekhara rasa(orally) with and without Brihata Dashmoola taila nasya(nasal drops).CTRI/2024/03/064422Institute of Teaching and Research in Ayurveda Jamnagar
Not yet recruiting
Phase 3
Role of Ayurveda in HypothyroidismCTRI/2023/04/051517Institute of Teaching and Research in Ayurveda Jamnagar 361008 GUJARAT
Not yet recruiting
Phase 3
snigdha (unctuous) and rooksha (dry)virechana in healthy individualsCTRI/2022/03/041436Institute of teaching and Research in Ayurveda Jamnagar
